| 000 | 01187 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514222122.0 | ||
| 264 | 0 | _c20050428 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a1568-0053 | ||
| 024 | 7 |
_a10.2174/1568005053174645 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorkow, G | |
| 245 | 0 | 0 |
_aMulti-targeting the entrance door to block HIV-1. _h[electronic resource] |
| 260 |
_bCurrent drug targets. Infectious disorders _cMar 2005 |
||
| 300 |
_a3-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCell Membrane Permeability _xdrug effects |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aHIV Infections _xmetabolism |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aReceptors, HIV _xantagonists & inhibitors |
| 700 | 1 | _aLapidot, A | |
| 773 | 0 |
_tCurrent drug targets. Infectious disorders _gvol. 5 _gno. 1 _gp. 3-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568005053174645 _zAvailable from publisher's website |
| 999 |
_c15449247 _d15449247 |
||